Business & Finance Merck tops quarterly estimates, hikes profit outlook as new Keytruda form shows strength
Merck's immunotherapy Keytruda, including a newer injectable form of the drug, showed stronger-than-expected sales.
By
· October 29, 2026 · 1 min read
This article was originally published by
CNBC Top News
and is republished here under license.
Merck’s immunotherapy Keytruda, including a newer injectable form of the drug, showed stronger-than-expected sales.
Related
The drugmaker continues to dominate the market for prescription weight-loss drugs in the U.S.…
By
· October 29, 2026 · 1 min read
America has always been a job-creating machine. It has broken down for three straight years, and the implications could be…
By
· October 29, 2026 · 1 min read
“I want to travel to Europe … How can I tell if something is a real experience in my price…
By
· October 29, 2026 · 1 min read
Leave a Reply